Maria A. Lizarralde-Iragorri

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial”.

Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial

Blood Advances(2023)10.1182/bloodadvances.2023011542

N/A

0.630DataRank · unranked

15 citations

Bindu Parachalil Gopalan, Brenda Merriweather, Jennifer Brooks, Mai Hill, Dianna Lovins +8 more

Sickle Cell Disease: A Paradigm for Venous Thrombosis Pathophysiology

International Journal of Molecular Sciences(2020)10.3390/ijms21155279

N/A

0DataRank · unranked

44 citations

Arun S. Shet, Maria A. Lizarralde-Iragorri

Incorporating point-of-care technologies to assess treatment response in sickle cell disease

Blood Vessels Thrombosis & Hemostasis(2024)10.1016/j.bvth.2024.100009

N/A

0DataRank · unranked

1 citations

Timothy Quang, Maria A. Lizarralde-Iragorri, Dianna Lovins, Ann Cullinane, Alina Dulau‐Florea +3 more